Viemed Healthcare Posts Record Growth as Sleep Services Overtake Ventilation

Stonegate Capital Partners has updated its coverage on Viemed Healthcare, Inc., highlighting a year of significant financial growth and strategic evolution for the home healthcare provider. The firm reported that Viemed achieved a 21% year-over-year increase in net revenue for FY25, reaching $270.3 million, alongside a record adjusted EBITDA of $61.4 million and a substantial 141% surge in free cash flow. This performance was driven by strong platform momentum and the integration of Lehan's, a key acquisition that broadens Viemed's commercial exposure and diversifies its payer mix. The company also benefited from the broader healthcare industry shift toward in-home care and accelerating adoption of its sleep therapy and resupply services. A notable headwind was a temporary moderation in ventilator patient growth due to an updated National Coverage Determination (NCD), which introduced new documentation requirements and tightened coverage criteria, though reimbursement levels remained unchanged and ventilator activity is reportedly normalizing.

Key takeaways from the analysis underscore a pivotal transformation in Viemed's business model. The company's sleep and resupply segments are now overtaking its traditional ventilation business, which improves the quality of its recurring revenue streams and reduces sensitivity to regulatory changes. The integration of Lehan's is seen as a strategic move that creates a longer runway for scaled growth by expanding Viemed's service offerings and market reach. Despite some margin mix pressure, Stonegate's FY26 guidance and valuation assessment suggest that Viemed's durable growth trajectory may still be underappreciated by the market. For those interested in the complete financial details and strategic insights, the full report is accessible by clicking here.

The announcement emphasizes the roles of both Viemed Healthcare, a NASDAQ-listed company specializing in in-home respiratory care and medical equipment, and Stonegate Capital Partners, the advisory firm providing this equity research update. Stonegate is described as a leading capital markets firm offering investor relations and research services, with an affiliate involved in investment banking. The news release directs readers to the source for more information, including downloadable images and bios, reinforcing the availability of comprehensive data through the provided hyperlink.